skip to Main Content

PUBLICATIONS

  1. Corsan GH, MacDonald PC, Casey, ML: Origin of deoxycorticosteroneDr. Corsan sulfate (DOC-SO4) in plasma of pregnant women: pregnenolone-3,21-disulfate is a placental precursor of DOC-SO4. J Steroid Biochem Mol Biol Mar;60(5-6):331-7, 1997.
  2. Corsan GH, Trias A, Trout S, Kemmann E: Superovulation combined with intrauterine insemination in women 40 years of age and older: is it worthwhile? Hum Reprod, 11, 5:1109- 1112, 1996.
  3. Karacan M, Shelden R, Corsan GH: Effect of 6-day workweek on cycle fecundity rates in controlled ovarian hyperstimulation-intrauterine insemination (COH-IUI) cycles in subfertile couples. J Reprod Med 41:767-771, 1996.
  4. Corsan GH, Karacan M, Qasim S, Bohrer M, Ransom MX, and Kemmann E: Identification of hormonal parameters for successful single-dose methotrexate therapy in ectopic pregnancy. Hum Reprod 10:2719-2722, 1995.
  5. Qasim SM, Karacan M, Corsan GH, Shelden R, Kemmann E: High- order oocyte transfer in gamete intrafallopian transfer patients 40 or more years of age. Fertil Steril 64:107-110, 1995.
  6. Corsan GH, Jow W, Qasim S, Karacan M: Laparoscopic gonadectomy in complete androgen insensitivity syndrome. J Am Assoc Gyn Laparoscopists; 2:87-89, 1994 .
  7. Ransom MX, Garcia AJ, Bohrer M, Corsan GH, Kemmann E: Serum progesterone as a predictor of methotrexate success in the treatment of ectopic pregnancy. Obstet Gynecol 83:1033, 1994.
  8. Ransom M, Corsan GH, Garcia AJ, Doherty KA, Kemmann E: Tubal selection for gamete intrafallopian transfer. Fertil Steril 61:386, 1994.
  9. Ransom M, Blotner M, Bohrer M, Corsan GH, Kemmann E: Does increasing frequency of intrauterine inseminations improve cycle fecundity significantly during superovulation cycles? Fertil Steril 61:303, 1994.
  10. Corsan GH, Blotner MB, Bohrer MK, Shelden R, Kemmann E: The utility of a home urinary luteinizing hormone immunoassay in timing the postcoital test. Obstet Gynecol 81:5, 1993.
  11. Corsan GH, Kemmann E, Bohrer, M, Blotner M, Smilow P, Shelden R: Use of urinary luteinizing hormone immunoassays in the assessment of luteal function in infertile women. Am J Obstet Gynecol 166:41, 1992.
  12. Corsan, GH, Kemmann E: Gonadotropin-releasing hormone agonist in a GIFT Program. New Jersey Med 89:275, 1992.
  13. Corsan GH: Conn’s Current Therapy: 1993. Ectopic pregnancy. Rakel, ed. W.B. Saunders Co., p 998, 1993.
  14. Kemmann E, Ghazi D, Corsan GH, Bohrer MK: Post-operative observation versus ovulation stimulation in patients with minimal/mild endometriosis treated by laser laparoscopy. Int J Fertil, 38(1):16-21, 1993.
  15. Corsan GH, Kemmann E: The role of superovulation with menotropins in ovulatory infertility: a review. Fertil Steril, 55:468, 1990.
  16. Corsan GH, Kemmann E: Risk of a second consecutive first-trimester spontaneous abortion in women who conceive with menotropins. Fertil Steril 53:817, 1990.
  17. Kemmann E, Ghazi D, Corsan GH: Adnexal torsion in menotropin-induced pregnancies. Obstet Gynecol, 76:403, 1990.
  18. Corsan GH, Ghazi D, Kemmann E: Home urinary luteinizing hormone (LH) immunoassays: clinical applications. Fertil Steril 53:591, 1990.
  19. Corsan GH, Nezhat F: Tuboovarian abscess resulting in loss of a kidney. A case report. Am J Gynecol Health 3:1, 1989.
  20. Corsan GH, Kemmann E, Shelden R: Multiple gestation with intrauterine insemination and menotropin therapy. (Letter) Am J Obstet Gynecol 161:1751, 1989.
  21. Corsan GH, Kemmann E: Role of repetitive hCG injections during the luteal phase in stimulated cycles. Letters-to-the-editor, Fertil Steril 51:549, 1989.
  22. Corsan GH, Carr BR: Expectant management of ectopics. Letters-to-the-Editor, Fertil Steril 50:380, 1988.

Abstracts:

  1. Trout S, Qasim S, Corsan G, Kemmann E: A prospective randomized study comparing fallopian sperm perfusion and intrauterine insemination. Presented at the 52nd Annual Meeting of the American Society of Reproductive Medicine, Boston, MA, November 1996.
  2. I El-Danasouri, S Trout, M Bohrer, G Corsan, R Sachdev, D Arbit, R Shelden, E Kemmann: Factors affecting the outcome of intracytoplasmic sperm injection. Presented at the 12th Annual Meeting of the European Society of Human Reproduction and Embryology, Maastricht, the Netherlands, June 30-July 3, 1996.
  3. I El-Danasouri, M Bohrer, G Corsan, R Sachdev, E Kemmann: Female chronological age determines the implantation rate during intracytoplasmic sperm injection. Presented at the Third World Conference on Early Pregnancy, Atlantic City, NJ, October, 1996.
  4. Trout S, Bohrer M, Corsan G, Sachdev R, Kemmann E: Is it worthwhile to perform intrauterine inseminations of less than one million motile sperm? Presented at the 51st Annual meeting of the American Society for Reproductive Medicine, Seattle, Washington, October 7-12, 1995.
  5. Karacan M, Qasim S, Corsan GH, Bohrer M, Kemmann E: Prediction of success of single-dose methotrexate (MTX) therapy in ectopic pregnancy (EP). Presented at the 50th Annual Meeting of The American Fertility Society, San Antonio, Texas, Nov. 1994.
  6. Shelden R, Kemmann E, Karacan M, Corsan G: Effect of 6-day work week on fecundity for controlled ovarian hyperstimulation-intrauterine insemination in subfertile couples. Presented at the Second World Conference on Implantation and Early Pregnancy in Humans, Atlantic City, May 1994.
  7. Ransom MX, Blotner MB, Bohrer M, Corsan GH, Shelden R, Cody R, Kemmann E: Cycle day 3 follicle-stimulating hormone (FSH) as a predictor of superovulation cycle performance. Presented at the 48th Annual Meeting of The American Fertility Society, New Orleans, LA, Dec. 1992.
  8. Corsan GH, Kemmann E: Experience with the use of sequential clomiphene ctrate/human menopausal gonadotropin therapy (CC/hMG) in infertility women. Presented at the 47th Annual Meeting of The American Fertility Society, Orlando, Florida, Nov. 1991.
  9. Corsan GH, Kemmann E, Blotner M, Bohrer M, Shelden R: The utility of urinary luteinizing hormone (LH) immunoassays in the performance of the postcoital test. Presented at the 47th Annual Meeting of The American Fertility Society, Orlando, Florida, Nov. 1991.
  10. Corsan GH, Smilow P, Shelden R, Kemmann E: Use of urinary luteinizing hormone immunoassays in the assessment of luteal function. Presented at the 46th Annual Meeting of The American Fertility Society, Washington, D.C., October, 1990.
  11. Corsan GH, Kemmann E: Risk of a second consecutive spontaneous abortion in human menopausal gonadotropin/human chorionic gonadotropin (hMG/hCG) cycles. Presented at the 45th Annual Meeting of The American Fertility Society, San Francisco, CA 1989.
  12. Corsan GH, Casey ML, MacDonald PC: The Origin of Deoxycorticosterone Sulfate (DOC-S04) in Plasma of Pregnant Women: Pregnenolone Sulfate as a Precursor. Proceedings of The Endocrine Society, p. 30, 1988 (abstract and slide presentation).
  13. Corsan GH, Casey ML, MacDonald PC: The Origin of Deoxycorticosterone Sulfate (DOC-S04) in Maternal Plasma: Fetal Plasma Pregnenolone-3, 21-Disulfate As a Placental Precursor of DOC-S04. Proceedings of The Society of Gynecological Investigation, p. 232, 1988.
  14. Byrd W, Carr BR, Corsan GH, et al: Artificial Insemination Using Frozen Donor Semen: A Randomized Study Comparing Intracervical and Intrauterine Insemination. 44th Annual Meeting of The American Fertility Society, October 10-13, p. S7, 1988.
Back To Top